What are the recommended adrenaline (epinephrine) doses for anaphylaxis, cardiac arrest, severe bronchospasm/asthma, and procedural sedation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Adrenaline Dosing Chart

Administer intramuscular adrenaline 0.3–0.5 mg (1:1000 concentration) into the anterolateral thigh immediately for anaphylaxis in adults, and use 1 mg IV/IO (1:10,000 concentration) every 3–5 minutes for cardiac arrest—these are the only evidence-based first-line doses that prevent death in their respective indications. 1, 2, 3


Anaphylaxis Dosing (Intramuscular Route)

Adult Dosing

  • Adults ≥30 kg: Administer 0.3–0.5 mg of 1:1000 adrenaline (1 mg/mL) intramuscularly into the mid-anterolateral thigh 1, 2, 3
  • Repeat interval: Every 5–15 minutes if symptoms persist or recur 1, 2, 3
  • Injection site rationale: The vastus lateralis achieves peak plasma concentrations in 8±2 minutes versus 34±14 minutes for subcutaneous administration 2, 4

Pediatric Dosing

  • Children <30 kg: Administer 0.01 mg/kg (maximum 0.3 mg) of 1:1000 adrenaline intramuscularly into the anterolateral thigh 1, 2, 3
  • Autoinjector dosing:
    • 0.15 mg for children 10–25 kg
    • 0.3 mg for individuals ≥25 kg
    • 0.1 mg for infants where available (if unavailable, 0.15 mg is appropriate for infants >7.5 kg) 2
  • Repeat interval: Every 5–15 minutes as needed 2, 3

Critical Safety Points

  • Never delay intramuscular adrenaline while establishing IV access—IM injection achieves therapeutic levels faster than waiting for IV placement 2
  • No absolute contraindications exist for adrenaline in anaphylaxis, even in elderly patients with cardiovascular disease 2
  • 10–20% of patients require more than one dose—prepare for repeat administration 2

Cardiac Arrest Dosing (Intravenous/Intraosseous Route)

Adult Dosing

  • Standard dose: 1 mg IV/IO (1:10,000 concentration = 0.1 mg/mL) every 3–5 minutes during ongoing resuscitation 1, 2
  • Timing for non-shockable rhythms (asystole/PEA): Administer as soon as feasible after arrest recognition 1
  • Timing for shockable rhythms (VF/VT): Administer after initial defibrillation attempts have failed 1

Pediatric Dosing

  • Children: 0.01 mg/kg (0.1 mL/kg of 1:10,000 solution) IV/IO every 3–5 minutes, maximum 1 mg per dose 1, 2
  • Higher doses for refractory arrest: 0.1–0.2 mg/kg (0.1 mL/kg of 1:1000 solution) may be considered for unresponsive asystole or pulseless electrical activity 1

High-Dose Epinephrine (NOT Recommended)

  • High-dose epinephrine (>1 mg) is NOT recommended for routine cardiac arrest—it does not improve survival to discharge or neurological outcomes 1

Anaphylaxis Progressing to Cardiac Arrest

Immediately abandon the 0.3–0.5 mg IM protocol and switch to cardiac arrest dosing of 1 mg IV/IO (1:10,000) every 3–5 minutes the moment the patient becomes pulseless. 1, 2

Transition Protocol

  • Witnessed anaphylaxis arrest: Begin high-quality CPR, obtain IV/IO access, and give 1 mg adrenaline (1:10,000) as soon as access is secured 1, 2
  • Rationale: During arrest, peripheral perfusion is absent, making IM absorption unpredictable; the 0.3–0.5 mg IM dose provides only 30–50% of the required cardiac arrest dose 2
  • Anaphylaxis-specific cardiac arrest dosing: For refractory anaphylactic arrest, consider high-dose IV adrenaline with rapid escalation: 1–3 mg (1:10,000) IV slowly over 3 minutes, then 3–5 mg IV over 3 minutes, then 4–10 mg/min infusion 1, 2

Refractory Anaphylaxis (IV Adrenaline)

When to Use IV Adrenaline

  • Consider IV route when: An IV line is already in place AND the patient has anaphylactic shock unresponsive to multiple IM doses 1, 2
  • Critical concentration: Use only 1:10,000 concentration (0.1 mg/mL) for IV administration—never use 1:1000 concentration IV, as it can cause fatal arrhythmias 2

IV Bolus Dosing

  • Adults: 50–100 mcg (0.05–0.1 mg) IV bolus using 1:10,000 concentration, titrated slowly to response 1, 2
  • Children: 1 mcg/kg IV bolus 2
  • Repeat interval: Every 5–15 minutes as needed 2

IV Infusion Dosing

  • Adults: 0.05–0.1 mcg/kg/min (approximately 1–4 mcg/min, maximum 10 mcg/min) 1, 2
  • Alternative preparation: Add 1 mg (1 mL of 1:1000) to 250 mL D5W for a 4 mcg/mL concentration, infuse at 1–4 mcg/min initially 2
  • Mandatory monitoring: Continuous cardiac monitoring and frequent blood pressure checks are required 1, 2

Severe Bronchospasm/Asthma

Adrenaline is NOT recommended for severe asthma exacerbations—use nebulized albuterol 2.5–5 mg in 3 mL saline (repeated as necessary) as the bronchodilator of choice. 1, 2

Bronchospasm Resistant to Epinephrine (in Anaphylaxis Context)

  • After adequate adrenaline doses for anaphylaxis: Consider inhaled β-agonist (nebulized albuterol 2.5–5 mg in 3 mL saline, repeat as necessary) 1, 2
  • Rationale: Albuterol treats bronchospasm but does NOT address airway edema or cardiovascular collapse 2

Special Populations & Modifiers

Patients on Beta-Blockers

  • May be refractory to adrenaline—administer glucagon 1–5 mg IV over 5 minutes (20–30 mcg/kg in children, maximum 1 mg), followed by infusion of 5–15 mcg/min 1, 2
  • Be aware: Glucagon may cause vomiting 2

Pregnant Patients

  • Position: Perform left uterine displacement to avoid aortocaval compression 2
  • Dosing: Standard adult anaphylaxis dosing applies 2

Fluid Resuscitation (Essential Adjunct)

  • Adults: Administer 5–10 mL/kg of isotonic crystalloid rapidly in first 5 minutes (approximately 1–2 L total); up to 20–30 mL/kg may be needed 2
  • Children: Give up to 30 mL/kg within the first hour 2
  • Rationale: Anaphylaxis causes massive vasodilation and capillary leak, with up to 35% of intravascular volume shifting extravascularly within minutes 2

Concentration & Route Error Prevention

Critical Distinctions

Indication Concentration Route Dose Frequency
Anaphylaxis 1:1000 (1 mg/mL) IM (thigh) 0.3–0.5 mg (adults) Every 5–15 min
Cardiac Arrest 1:10,000 (0.1 mg/mL) IV/IO 1 mg Every 3–5 min
Refractory Anaphylaxis 1:10,000 (0.1 mg/mL) IV (slow push) 50–100 mcg Every 5–15 min

Safety Strategies

  • Pre-filled syringes: Hospitals should stock clearly labeled, color-coded pre-filled syringes that differentiate IM (1:1000) from IV/IO (1:10,000) adrenaline 2
  • Double-check protocol: Before administration, verify (1) indication (anaphylaxis vs. cardiac arrest), (2) concentration (1:1000 vs. 1:10,000), (3) route (IM thigh vs. IV/IO), and (4) weight-based dose for children 2
  • Physical separation: Store IM and IV preparations in distinct locations on the emergency cart with different color codes 2

Common Pitfalls to Avoid

  • Do NOT delay IM adrenaline while establishing IV access in anaphylaxis—IM achieves therapeutic levels in 8 minutes 2, 4
  • Do NOT use 1:1000 concentration for IV administration—only 1:10,000 is safe for IV route 2
  • Do NOT rely on antihistamines or corticosteroids to treat airway obstruction or cardiovascular collapse—they are second-line adjuncts only 1, 2
  • Do NOT continue IM dosing once cardiac arrest occurs—immediately switch to 1 mg IV/IO cardiac arrest protocol 2
  • Do NOT administer repeated injections at the same site—resulting vasoconstriction may cause tissue necrosis 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Epinephrine Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Epinephrine (adrenaline) in anaphylaxis.

Chemical immunology and allergy, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.